Publication | Closed Access
The efficacy and safety of oral low dose naltrexone versus placebo in the patients with lichen planopilaris: a randomized controlled clinical trial
11
Citations
9
References
2020
Year
Low-dose naltrexone (3 mg) failed to improve the severity of the LPP more than what is achievable with topical clobetasol.
| Year | Citations | |
|---|---|---|
Page 1
Page 1